| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1377184 | Bioorganic & Medicinal Chemistry Letters | 2007 | 5 Pages |
Abstract
We report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in vitro.
Graphical abstractWe report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in vitro.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Mike Frohn, Han Xu, Xiaoming Zou, Catherine Chang, Michele McElvaine, Matthew H. Plant, Min Wong, Philip Tagari, Randall Hungate, Roland W. Bürli,